Alvotech (ALVO) Receivables - Net (2020 - 2026)
Alvotech's (ALVO) quarterly Receivables - Net came in at $46.6 million in Q2 2026, down 56.91% on a YoY basis from $108.1 million in Q2 2025, and down 2.6% quarter-over-quarter from $47.8 million in Q1 2026.
Analysis
Alvotech (ALVO) Receivables - Net (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Receivables - Net for 7 consecutive years, with $46.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Receivables - Net fell 56.91% year-over-year to $46.6 million; the trailing twelve-month figure through Jun 2026 stood at $46.6 million (down 56.91% YoY), and the FY2025 full-year result was $69.7 million, down 56.47% from the prior year.
- Receivables - Net declined to $46.6 million in Q2 2026 per ALVO's latest filing, from $47.8 million in the prior quarter.
- Across five years, Receivables - Net topped out at $168.3 million in Q1 2025 and bottomed at $5.3 million in Q2 2022.
- Historically, Receivables - Net has averaged $76.4 million across 5 years, with a median of $58.8 million in 2025.
- The sharpest annual moves came in 2024 and 2026: Receivables - Net soared 473.5% in 2024, then sank 71.59% in 2026.
- Over 5 years, Receivables - Net stood at $33.0 million in 2022, then advanced by 25.23% to $41.3 million in 2023, then jumped by 288.01% to $160.2 million in 2024, then plunged by 56.47% to $69.7 million in 2025, then sank by 33.21% to $46.6 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $46.6 million, $47.8 million, and $69.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.58 Mn |
| Mar 31, 2026 | 47.82 Mn |
| Dec 31, 2025 | 69.74 Mn |
| Sep 30, 2025 | 160.22 Mn |
| Jun 30, 2025 | 108.10 Mn |
| Mar 31, 2025 | 168.32 Mn |
| Dec 31, 2024 | 160.22 Mn |
| Sep 30, 2024 | 77.42 Mn |
| Jun 30, 2024 | 93.52 Mn |
| Mar 31, 2024 | 41.25 Mn |
| Dec 31, 2023 | 41.29 Mn |
| Jun 30, 2023 | 16.31 Mn |
| Dec 31, 2022 | 32.97 Mn |
| Jun 30, 2022 | 5.30 Mn |
| Dec 31, 2021 | 29.40 Mn |
| Dec 31, 2020 | 583,000.00 |